HCSG vs DBVT vs ALKS vs AMSF

For growth investors, Healthcare Services Group, Inc.

(HCSG) is the stronger pick with 7. 1% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). AMERISAFE, Inc. (AMSF) offers the better valuation at 12. 0x trailing P/E (14. 2x forward), making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, AMERISAFE, Inc.

(AMSF) is the cheapest at 12. 0x versus Healthcare Services Group, Inc. at 26. 8x. On forward P/E, AMERISAFE, Inc. is actually cheaper at 14. 2x.

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +64.

4%, compared to -69. 6% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: AMSF returned +34. 7% versus DBVT's -87. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), AMERISAFE, Inc.

(AMSF) is the lower-risk stock at 0. 23β versus DBV Technologies S. A. 's 1. 26β — meaning DBVT is approximately 444% more volatile than AMSF relative to the S&P 500. On balance sheet safety, AMERISAFE, Inc. (AMSF) carries a lower debt/equity ratio of 0% versus 13% for DBV Technologies S. A. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Healthcare Services Group, Inc.

(HCSG) is pulling ahead at 7. 1% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc. grew EPS 52. 8% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, ALKS leads at 9. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus 0. 0% for DBV Technologies S. A. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMSF leads at 18. 6% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — ALKS leads at 86. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, AMERISAFE, Inc.

(AMSF) trades at 14. 2x forward P/E versus 20. 3x for Healthcare Services Group, Inc. — 6. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 137. 7% to $46. 33.

In this comparison, AMSF (8.

6% yield) pays a dividend. HCSG, DBVT, ALKS do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, AMERISAFE, Inc.

(AMSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 8. 6% yield). Both have compounded well over 10 years (AMSF: +34. 7%, DBVT: -87. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HCSG (Healthcare) and DBVT (Healthcare) and ALKS (Unknown) and AMSF (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HCSG is a small-cap quality compounder stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; AMSF is a small-cap deep-value stock. AMSF pays a dividend while HCSG, DBVT, ALKS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.